<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Vetoquinol&amp;#39;s new three monthly feline parasiticide gets marketing authorisation</title><link>/b/veterinary-nursing-news/posts/vetoquinol-s-new-three-monthly-feline-parasiticide-gets-marketing-authorisation</link><description> Vetoquinol has been granted EU marketing authorisation for Felpreva (tigolaner/emodepside/praziquantel) for spot-on prevention and treatment of mixed parasitic infestations/infections in cats 1 . 
 Felpreva is the first spot-on parasiticide for cats</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>